<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>17(4)</volume><submitter>Koh J</submitter><pubmed_abstract>&lt;h4>Background&lt;/h4>Impulse control disorders are detrimental neuropsychiatric symptoms of Parkinson's disease. Increased impulsivity is a predisposing factor for impulse control disorders and should therefore be controlled. Recently, mindfulness meditation as a non-drug therapy has been reported to be useful in improving neuropsychiatric symptoms, such as impulsivity.&lt;h4>Methods&lt;/h4>We performed a prospective single-arm, open-label pilot trial to investigate the effectiveness of mindfulness meditation to control impulsivity in patients with Parkinson's disease (UMIN clinical trials registry: UMIN000037779).&lt;h4>Results&lt;/h4>Twenty patients with Parkinson's disease were enrolled in an 8-week mindfulness meditation program. As a primary outcome, we investigated whether the score of the Barratt</pubmed_abstract><journal>PloS one</journal><pagination>e0266354</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8985985</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>A single-arm open-label pilot study of brief mindfulness meditation to control impulsivity in Parkinson's disease.</pubmed_title><pmcid>PMC8985985</pmcid><pubmed_authors>Ohmae Y</pubmed_authors><pubmed_authors>Taruya J</pubmed_authors><pubmed_authors>Yasui M</pubmed_authors><pubmed_authors>Ito H</pubmed_authors><pubmed_authors>Koh J</pubmed_authors><pubmed_authors>Takahashi M</pubmed_authors><pubmed_authors>Terada M</pubmed_authors><pubmed_authors>Sakata M</pubmed_authors></additional><is_claimable>false</is_claimable><name>A single-arm open-label pilot study of brief mindfulness meditation to control impulsivity in Parkinson's disease.</name><description>&lt;h4>Background&lt;/h4>Impulse control disorders are detrimental neuropsychiatric symptoms of Parkinson's disease. Increased impulsivity is a predisposing factor for impulse control disorders and should therefore be controlled. Recently, mindfulness meditation as a non-drug therapy has been reported to be useful in improving neuropsychiatric symptoms, such as impulsivity.&lt;h4>Methods&lt;/h4>We performed a prospective single-arm, open-label pilot trial to investigate the effectiveness of mindfulness meditation to control impulsivity in patients with Parkinson's disease (UMIN clinical trials registry: UMIN000037779).&lt;h4>Results&lt;/h4>Twenty patients with Parkinson's disease were enrolled in an 8-week mindfulness meditation program. As a primary outcome, we investigated whether the score of the Barratt</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022</publication><modification>2025-04-05T13:24:06.614Z</modification><creation>2025-04-05T13:24:06.614Z</creation></dates><accession>S-EPMC8985985</accession><cross_references><pubmed>35385563</pubmed><doi>10.1371/journal.pone.0266354</doi></cross_references></HashMap>